KRAS and cancer: In particular, HBP, driven by oncogenic K-RAS expression and hypoxia, provides precursors for protein N- and O-glycosylation, whose involvement in cancer proliferation, survival, and metastasis, and, almost as importantly, cancer cell metabolism has been recently and widely shown [62,70,71].